Search research articles
Contact Us
Filters
Showing results (11-20 of 142) with videos related to
Page
of 15
Sort By:
Cancer Research
|
October 8, 2009
Differences in tumor regulatory T-cell localization and activation status impact patient outcome
Christine Ménétrier-Caux, Michael Gobert, Christophe Caux
Bulletin Du Cancer
|
January 19, 2024
[Cell therapy in all its forms]
Aurore Dougé, Christophe Caux, Jacques-Olivier Bay
Seminars in Cancer Biology
|
April 3, 2002
Tumour escape from immune surveillance through dendritic cell inactivation
Alain P Vicari, Christophe Caux, Giorgio Trinchieri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2014
Intratumoral immunization: a new paradigm for cancer therapy
Aurélien Marabelle, Holbrook Kohrt, Christophe Caux, et al.
Mutagenesis
|
February 18, 2015
Paradigm shift in oncology: targeting the immune system rather than cancer cells
Tala Shekarian, Sandrine Valsesia-Wittmann, Christophe Caux, et al.
Oncoimmunology
|
December 8, 2018
MDR1 in immunity: friend or foe?
Marion Bossennec, Anthony Di Roio, Christophe Caux, et al.
Bulletin Du Cancer
|
May 7, 2023
[Tertiary lymphoid structures in cancer: From biology to therapeutic guides]
Stanislas Quesada, Coriolan Lebreton, Christophe Caux, et al.
Targeted Oncology
|
March 9, 2012
Targeting pattern recognition receptors in cancer immunotherapy
Nadège Goutagny, Yann Estornes, Uzma Hasan, et al.
Trends in Immunology
|
September 14, 2010
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
Ivan Hirsch, Christophe Caux, Uzma Hasan, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 142) with videos related to
Sort By:
Page
of 15
Cancer Research
|
October 8, 2009
Differences in tumor regulatory T-cell localization and activation status impact patient outcome
Christine Ménétrier-Caux, Michael Gobert, Christophe Caux
Bulletin Du Cancer
|
January 19, 2024
[Cell therapy in all its forms]
Aurore Dougé, Christophe Caux, Jacques-Olivier Bay
Seminars in Cancer Biology
|
April 3, 2002
Tumour escape from immune surveillance through dendritic cell inactivation
Alain P Vicari, Christophe Caux, Giorgio Trinchieri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2014
Intratumoral immunization: a new paradigm for cancer therapy
Aurélien Marabelle, Holbrook Kohrt, Christophe Caux, et al.
Mutagenesis
|
February 18, 2015
Paradigm shift in oncology: targeting the immune system rather than cancer cells
Tala Shekarian, Sandrine Valsesia-Wittmann, Christophe Caux, et al.
Oncoimmunology
|
December 8, 2018
MDR1 in immunity: friend or foe?
Marion Bossennec, Anthony Di Roio, Christophe Caux, et al.
Bulletin Du Cancer
|
May 7, 2023
[Tertiary lymphoid structures in cancer: From biology to therapeutic guides]
Stanislas Quesada, Coriolan Lebreton, Christophe Caux, et al.
Targeted Oncology
|
March 9, 2012
Targeting pattern recognition receptors in cancer immunotherapy
Nadège Goutagny, Yann Estornes, Uzma Hasan, et al.
Trends in Immunology
|
September 14, 2010
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
Ivan Hirsch, Christophe Caux, Uzma Hasan, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.
Page
of 15